Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...

The global mycoplasma testing market is projected to grow at a robust 11% CAGR from 2022 to 2027. Key drivers include expanding R&D activities and investments, increased government funding initiatives ...

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is. Mycoplasmas are the smallest free-living ...

After a microbiology-filled academic and research career, Diana Patzelt became the Global Project Manager for Microbial Enumeration Products at Sartorius (Göttingen, Germany), earning her the title of ...

Mycoplasma contamination is a persistent issue in cell culture and biopharmaceutical manufacturing. Mycoplasmas are widespread in the environment and are commonly found on human mucosal surfaces.

The rapid growth of the biologics safety testing market has led to the need for more testing capabilities in manufacturing and clinical research. Industry guidelines require biopharmaceutical and ...

FREMONT, Calif. and SARANAC LAKE, N.Y., March 20, 2025 /PRNewswire/ -- Bionova Scientific, a boutique commercial-scale biologics contract development and manufacturing organization (CDMO), announced ...

Cell culture is a deliciously inviting hub for bacteria, fungi, and mycoplasmas. However, as our own 'cell-culture sleuth' points out, failing to detect and eliminate contamination can alter all ...

THE WOODLANDS, Texas and SARANAC LAKE, N.Y., May 29, 2025 /PRNewswire/ -- Bionique Testing Laboratories, a global leader in mycoplasma testing services and part of the Asahi Kasei group, and Cellipont ...

Infections of mycoplasma pneumoniae, also known as “walking pneumonia,” are on the rise in the United States, particularly among children, according to recently released data from the Centers for ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to ...